Quality of life in patients by head and neck cancer treated by radiotherapy: a prospective self-assessment with the EORTC QLQ-C30 and QLQ-H&N35 questionnaires
DOI:
https://doi.org/10.6016/ZdravVestn.3157Keywords:
head and neck cancer, radiotherapy, quality of life, assessment, questionnaireAbstract
Background: The quality of life (QoL) of Slovenian patients with head and neck cancer (HNC) treated by radiotherapy (RT) has not yet been systematically evaluated with internationally established tools, which would allow comparison with the study results from abroad.
Methods: Forty patients with HNC treated by definitive (N=23) or postoperative (N=17) RT completed two questionnaires of the European Organization for Research and Treatment of Cancer (EORTC), validated and translated into Slovenian, before RT, at the end of RT and 10-12 weeks after the end of treatment: general QLQ-C30 questionnaire for patients with different types of cancer and QLQ-H&N35 questionnaire for patients with HNC. Statistically significant differences between the two measurements of 10 points or more were defined as clinically significant.
Results: Prior to RT, patients with tracheostomy or feeding tube, smokers, patients with comorbidities and human papillomavirus-unrelated cancers had poorer QoL. The intensity of treatment (higher RT dose, addition of chemotherapy to RT) had a significant effect on QoL at the end of RT, but not 10-12 weeks after treatment. The analysis of the dynamics of changes in QoL items confirmed that in most cases the scores return to the level before the start of RT. The exceptions were items related to RT-specific gustatory and salivary apparatus failures: their final score was significantly worse than the pre-RT score.
Conclusion: Estimates of different QoL items in Slovenian patients with HNC before, during and after RT are comparable to the results of similar analyses abroad. After RT treatment, QoL depends mainly on the degree of damage to the gustatory and salivary apparatus, which also affects swallowing.
Downloads
References
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
DOI: 10.3322/caac.21492
PMID: 30207593
2. Rak v Sloveniji. Ljubljana: Onkološki inštitut Ljubljna; Epidemiologija in register raka; Register raka Slovenije; 2019.
3. Mehanna H, Paleri V, West CM, Nutting C. Head and neck cancer-part 1: epidemiology, presentation, and preservation. Clin Otolaryngol. 2011;36(1):65-8.
DOI: 10.1111/j.1749-4486.2010.02231.x
PMID: 21414154
4. Primdahl H, Nielsen AL, Larsen S, Andersen E, Ipsen M, Lajer C, et al.; DAHANCA. Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: a Danish nationwide survey from DAHANCA. Acta Oncol. 2006;45(2):156-61.
DOI: 10.1080/02841860500423948
PMID: 16546860
5. Strojan P, Hutcheson KA, Eisbruch A, Beitler JJ, Langendijk JA, Lee AW, et al. Treatment of late sequelae after radiotherapy for head and neck cancer. Cancer Treat Rev. 2017;59:79-92.
DOI: 10.1016/j.ctrv.2017.07.003
PMID: 28759822
6. Checcoli E, Bianchini C, Ciorba A, Candiani M, Riberti C, Pelucchi S, et al. Reconstructive head and neck surgery: oncological and functional results. Tumori. 2013;99(4):493-9.
DOI: 10.1177/030089161309900409
PMID: 24326838
7. Efficace F, Osoba D, Gotay C, Sprangers M, Coens C, Bottomley A. Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making. Ann Oncol. 2007;18(4):775-81.
DOI: 10.1093/annonc/mdl494
PMID: 17259641
8. Leplège A, Hunt S. The problem of quality of life in medicine. JAMA. 1997;278(1):47-50.
DOI: 10.1001/jama.1997.03550010061041
PMID: 9207338
9. Rogers SN, Semple C, Babb M, Humphris G. Quality of life considerations in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130:S49-52.
DOI: 10.1017/S0022215116000438
PMID: 27841117
10. Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer. 2001;37(11):1345-51.
DOI: 10.1016/S0959-8049(00)00447-0
PMID: 11435063
11. Sobin LH, Gospodarowicz M, Wittekind C, eds. International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. 7th ed. Oxford (UK): Wiley-Blackwel; 2010. pp. 25-45.
12. European Organisation for Research and Treatment of Cancer. Quality of Life. Questionnaires. Brussels: EORTC; 2020 [cited 2020 Aug 10]. Available from: https://qol.eortc.org/questionnaires/.
13. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365-76.
DOI: 10.1093/jnci/85.5.365
PMID: 8433390
14. Singer S, Arraras JI, Chie WC, Fisher SE, Galalae R, Hammerlid E, et al. Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: a methodological review. Qual Life Res. 2013;22(8):1927-41.
DOI: 10.1007/s11136-012-0325-1
PMID: 23188134
15. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A; EORTC Quality of Life Group. The EORTC QLQ-C30 Scoring Manual. 3rd ed. Brussels: European Organisation for Research and Treatment of Cancer; 2001.
16. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139-44.
DOI: 10.1200/JCO.1998.16.1.139
PMID: 9440735
17. van Nieuwenhuizen AJ, Buffart LM, Brug J, Leemans CR, Verdonck-de Leeuw IM. The association between health related quality of life and survival in patients with head and neck cancer: a systematic review. Oral Oncol. 2015;51(1):1-11.
DOI: 10.1016/j.oraloncology.2014.09.002
PMID: 25262163
18. Terrell JE, Ronis DL, Fowler KE, Bradford CR, Chepeha DB, Prince ME, et al. Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2004;130(4):401-8.
DOI: 10.1001/archotol.130.4.401
PMID: 15096421
19. King SN, Dunlap NE, Tennant PA, Pitts T. Pathophysiology of radiation induced dysphagia in head and neck cancer. Dysphagia. 2016;31(3):339-51.
DOI: 10.1007/s00455-016-9710-1
PMID: 27098922
20. Han P, Suarez-Durall P, Mulligan R. Dry mouth: a critical topic for older adult patients. J Prosthodont Res. 2015;59(1):6-19.
DOI: 10.1016/j.jpor.2014.11.001
PMID: 25498205
21. Marur S, D’Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11(8):781-9.
DOI: 10.1016/S1470-2045(10)70017-6
PMID: 20451455
22. Rogers SN, Waylen AE, Thomas S, Penfold C, Pring M, Waterboer T, et al. Quality of life, cognitive, physical and emotional function at diagnosis predicts head and neck cancer survival: analysis of cases from the Head and Neck 5000 study. Eur Arch Otorhinolaryngol. 2020;277(5):1515-23.
DOI: 10.1007/s00405-020-05850-x
PMID: 32062743
23. Niska JR, Thorpe CS, Halyard MY, Tan AD, Atherton PJ, Dueck AC, et al. Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy. J Patient Rep Outcomes. 2020;4(1):60.
DOI: 10.1186/s41687-020-00227-4
PMID: 32677021
24. Al-Mamgani A, van Rooij P, Tans L, Verduijn GM, Sewnaik A, Baatenburg de Jong RJ. A prospective evaluation of patient-reported quality-of-life after (chemo)radiation for oropharyngeal cancer: which patients are at risk of significant quality-of-life deterioration? Radiother Oncol. 2013;106(3):359-63.
DOI: 10.1016/j.radonc.2012.12.014
PMID: 23395066
25. Karimi AM, Gairola M, Ahlawat P, Tandon S, Pal M, Sachdeva N, et al. Health-related quality of life assessment for head-and-neck cancer patients during and at 3 months after radiotherapy - A prospective, analytical questionnaire-based study. Natl J Maxillofac Surg. 2019;10(2):134-40.
DOI: 10.4103/njms.NJMS_92_18
PMID: 31798246
26. Pezdirec M, Strojan P, Boltezar IH. Swallowing disorders after treatment for head and neck cancer. Radiol Oncol. 2019;53(2):225-30.
DOI: 10.2478/raon-2019-0028
PMID: 31194691
27. Sprangers MA, Schwartz CE. The challenge of response shift for quality-of-life-based clinical oncology research. Ann Oncol. 1999;10(7):747-9.
DOI: 10.1023/A:1008305523548
PMID: 10470418
28. Abel E, Silander E, Nyman J, Björk-Eriksson T, Hammerlid E. Long-term aspects of quality of life in head and neck cancer patients treated with intensity modulated radiation therapy: A 5-year longitudinal follow-up and comparison with a normal population cohort. Adv Radiat Oncol. 2019;5(1):101-10.
DOI: 10.1016/j.adro.2019.07.015
PMID: 32051896
29. Ge X, Liao Z, Yuan J, Mao D, Li Y, Yu E, et al. Radiotherapy-related quality of life in patients with head and neck cancers: a meta-analysis. Support Care Cancer. 2020;28(6):2701-12.
DOI: 10.1007/s00520-019-05077-5
PMID: 31673782
30. Li X, Lee A, Cohen MA, Sherman EJ, Lee NY. Past, present and future of proton therapy for head and neck cancer. Oral Oncol. 2020;110:104879.
DOI: 10.1016/j.oraloncology.2020.104879
PMID: 32650256
Downloads
Published
Issue
Section
License
The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
